🔗 Visit the ClinicalTrials.gov page for NCT00169468
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. | N Engl J Med | 2002 | 19.60 |
| 2 | Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. | J Clin Oncol | 1999 | 2.36 |
| 3 | Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II. | J Natl Compr Canc Netw | 2004 | 0.75 |